Imipramine hydrochloride
-
Imipramine hydrochloride
structure -
-
CAS No:
113-52-0
-
Formula:
C19H24N2.ClH
-
Chemical Name:
Imipramine hydrochloride
-
Synonyms:
5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N-dimethyl-,hydrochloride (1:1);5H-Dibenz[b,f]azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-,monohydrochloride;5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N-dimethyl-,monohydrochloride;G 22355;5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenz[b,f]azepine hydrochloride;N-(γ-Dimethylaminopropyl)iminodibenzyl hydrochloride;N-(3-Dimethylaminopropyl)iminodibenzyl hydrochloride;Imipramine hydrochloride;Tofranil;Imizine;Melipramine hydrochloride;Imizin;Imipramine monohydrochloride;Tofranile;Teperine;Feinalmin;Irmin;Novo-pramine;Timolet;Eupramin;Censtim;Censtin;Surplix;SK-Pramine;Imizinum;Pryleugan;Intalpram;Tipramine;Chrytemin;Apo-Imipramine;Praminil;Imidobenzyle;Iramil;Imidol;DIPD;Janimine;Imiprin;Impril;Imavate;Imilanyle;Efuranol;Promiben;Dimipressin;Deprinol;Presamine;Dyna-Zina;Depsol;Melipramin
- Categories:
-
CAS No:
Description
Imipramine hydrochloride inhibits serotonin transporter with an IC50 value of 32 nM in vitro.
Imipramine Hydrochloride is the hydrochloride salt form of imipramine, a synthetic tricyclic derivative, antidepressant Imipramine enhances monoamine neurotransmission in certain areas of the brain. It also induces sedation through histamine 1 receptor blockage; hypotension through beta-adrenergic blockage; and diverse parasympatholytic effects. Imipramine has less sedative effect than other members of its therapeutic family. It is used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. (NCI04)|The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
Imipramine hydrochloride Basic Attributes
316.87
316.170624
204-030-7
BKE5Q1J60U
757074|114900
DTXSID7040738
C29116
Characteristics
6.5
4.74200
UN 1230 3/PG 2
1.041g/cm3
174-175 °C
160 DEG C @ 0.1 MM HG
179.7ºC
>47.5 [ug/mL]
2-8ºC
6.6E-06mmHg at 25°C
165.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
UN 1230 3/PG 2
3
R23/25
7-16-24-33-45-36-26
HO1925000
Xn: Harmful;
Imipramine hydrochloride turns yellowish or reddish on exposure to light; slight discoloration does not affect potency, but marked discoloration is associated with loss of potency. Solutions of imipramine hydrochloride are stable at pH 4-5. During storage, minute crystals may form in the injection; the efficacy of the preparation is unaltered if the crystals are redissolved by immersing the ampul in hot water for 1 minute. /Imipramine hydrochloride/
P301 + P312 + P330
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 92 companies from 4 notifications to the ECHA C&L Inventory.
Drug Information
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)|Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)
4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2)
Imipramine hydrochloride Use and Manufacturing
5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, hydrochloride (1:1): INACTIVE
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:316.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:4
Exact Mass:316.1706265
Monoisotopic Mass:316.1706265
Topological Polar Surface Area:6.5
Heavy Atom Count:22
Complexity:291
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a tricyclic antidepressant, and its main function is to block the reuptake of norepinephrine and 5-hydroxytryptamine by the central nervous system, thereby increasing the concentration of these two neurotransmitters in the synaptic cleft and exerting an antidepressant effect. This product also has anticholinergic, anti-α1 adrenergic receptor and anti-H1 histamine receptor effects, but has little effect on dopamine receptors.
Registered Holders
-
R L Fine Chem Pvt.Ltd.
Active
Japan
-
LUPIN LTD
Active
United Kingdom
-
TAPI NL B.V.
Active
France
Recommended Suppliers of Imipramine hydrochloride
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9